Description: Rabbit polyclonal antibody to WDR43 Immunogen: KLH-conjugated synthetic peptide encompassing a sequence within the C-terminal region of human WDR43. The exact sequence is proprietary. Purification: The antibody was purified by immunogen affinity chromatography. Clonality: Polyclonal Form: Liquid in 0.42% Potassium phosphate, 0.87% Sodium chloride, pH 7.3, 30% glycerol, and 0.01% sodium azide. Dilution: WB (1/500 - 1/1000), IH (1/50 - 1/200), FC (1/10 - 1/50) Gene Symbol: WDR43 Alternative Names: KIAA0007; UTP5; WD repeat-containing protein 43Entrez Gene (Human): 23160SwissProt (Human): Q15061Storage/Stability : Shipped at 4°C. Upon delivery aliquot and store at -20°C for one year. Avoid freeze/thaw cycles.
-
Western blot analysis of WDR43 expression in Jurkat (A), HepG2 (B) whole cell lysates.
-
Immunohistochemical analysis of WDR43 staining in human cervix carcinoma formalin fixed paraffin embedded tissue section. The section was pre-treated using heat mediated antigen retrieval with sodium citrate buffer (pH 6.0). The section was then incubated with the antibody at room temperature and detected using an HRP conjugated compact polymer system. DAB was used as the chromogen. The section was then counterstained with haematoxylin and mounted with DPX.
-
Flow cytometric analysis of HepG2 cells using Anti-WDR43 Antibody. The cells were fixed with 2% paraformaldehyde (10 min) and then permeabilized with 90% methanol for 10 min. The cells were incubated in 2% bovine serum albumin to block non-specific protein-protein interactions followed by the antibody at 37 °C for 60 min. The secondary antibody Goat Anti-Rabbit IgG (H&L) - AF488 was incubated at 37 °C for 40 min. Isotype control antibody (blue line) was used under the same condition.